To Detect the Sensitivity of the UroMark Assay

CompletedOBSERVATIONAL
Enrollment

1,643

Participants

Timeline

Start Date

September 26, 2016

Primary Completion Date

December 19, 2018

Study Completion Date

December 19, 2018

Conditions
Bladder Cancer
Trial Locations (19)

Unknown

Tameside General Hospital, Ashton-under-Lyne

East Lancashire Hospitals NHS Trust, Blackburn

Royal Bolton Hospital, Bolton

The Pennine Acute Hospitals NHS Trust, Bury

University Hospital Coventry, Coventry

Medway Maritime Hospital, Gillingham

Royal Free London NHS Foundation Trust, London

Macclesfield Hospital, Macclesfield

Norfolk & Norwich University Hospital, Norwich

King's Mill Hospital, Nottingham

East Surrey Hospital, Redhill

Northern Lincolnshire & Goole NHS Foundation Trust, Scunthorpe

Western Sussex Hospitals NHS Foundation Trust, Shoreham-by-Sea

Royal Shrewsbury Hospital, Shrewsbury

Stepping Hill Hospital, Stockport

University Hospital of North Tees, Stockton-on-Tees

Royal Albert Edward Infirmary, Wigan

New Cross Hospital, Wolverhampton

W1G 8PH

University College London Hospital, London

All Listed Sponsors
lead

University College, London

OTHER

NCT02781428 - To Detect the Sensitivity of the UroMark Assay | Biotech Hunter | Biotech Hunter